genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
Neuroscience
Could Parkinson’s Disease Be Triggered by Gut Infection Years before Symptoms…
News
Astellas, Frequency Therapeutics Partner to Develop Hearing Loss Drug
Tech Exclusives
microRNA’s Role in Cell Nucleus Gene Expression May Advance Gene Therapy
News
Semi-Synthetic Organism Is Put Through Its Protein-Production Paces
Boehringer Ingelheim
Expanding Cancer Immunotherapy Focus, Boehringer Ingelheim Acquires AMAL Therapeutics for Up-to-€325M
Insights
Insights
Top 10 Biopharma IPOs of January–June 2019
Tech Exclusives
A Toolbox for Keeping CRISPR in Check
Tech Exclusives
Drones Land in the Cell and Gene Therapy Space
Tech Exclusives
An Integrated Digital Vision for Biomanufacturing’s Future
Tech Exclusives
CRISPR and LASER ART Eliminate HIV from Mice
A-Lists
Insights
Top 10 Biopharma IPOs of January–June 2019
Insights
Top 10 M&A Deals of January–June 2019
Insights
The Top 10 Highest-Paid Women Executives in Biopharma
Insights
Top 50 NIH-Funded Institutions of 2019
July 2019 Vol. 39 No. 7
25 Up-and-Coming Gene Therapies of 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Neuroscience
Could Parkinson’s Disease Be Triggered by Gut Infection Years before Symptoms…
News
Astellas, Frequency Therapeutics Partner to Develop Hearing Loss Drug
Tech Exclusives
microRNA’s Role in Cell Nucleus Gene Expression May Advance Gene Therapy
News
Semi-Synthetic Organism Is Put Through Its Protein-Production Paces
Magazine
July 2019 Vol. 39 No. 7
CRISPR-Accelerated Gene Drives Pump the Brakes
July 2019 Vol. 39 No. 7
CRISPR Cinema: Scenes from the Cutting Edge
Tech Exclusives
Immunotherapy Targets Emerging Infectious Diseases
July 2019 Vol. 39 No. 7
Single-Cell Sequencing Sifts through Multiple Omics
Tech Exclusives
Bioreactor Design Adapts to Biopharma’s Changing Needs
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
GENcast
GENcast: A Biological GPS That Guides Awareness through Cellular Space
July 2019 Vol. 39 No. 7
Full-Length Transcript Sequencing—No Assembly Required
July 2019 Vol. 39 No. 7
Plasma Proteomics with NanoLC-MS
July 2019 Vol. 39 No. 7
Advanced Mass Spectrometry Drives Translational Cancer Biomarker Research beyond Discovery
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
Therapeutics
Autoimmune Disease Drugs
Autoimmune Disease Drugs
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Autoimmune Disease Drugs
New Work Opens Door to Manipulating Aberrant Calcium Signaling in Immune System
Autoimmune Disease Drugs
GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development
Autoimmune Disease Drugs
GSK Ends Effort to Commercialize Basilea’s Eczema Drug in U.S.
Autoimmune Disease Drugs
Technique Converts Harmful Autoantibodies into Anti-Inflammatory Antibodies In Vivo
Autoimmune Disease Drugs
Top 10 GEN News Articles of 2018
Autoimmune Disease Drugs
Novartis’ Sandoz Buys European Rights to Biosimilar Remicade
Autoimmune Disease Drugs
Immune Disorder Trigger Identified
Autoimmune Disease Drugs
argenx Plans Autoimmune Treatments Using Halozyme’s ENHANZE Drug-Delivery Technology
Autoimmune Disease Drugs
Lupus: Scientists Uncover Why Some Immune Cells Go Rogue
Autoimmune Disease Drugs
Testosterone-Activated Anti-MS Mechanism Could Protect Women
Autoimmune Disease Drugs
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
Autoimmune Disease Drugs
Immunotherapy Slashes Rheumatoid-Associated Heart Disease Risk
Autoimmune Disease Drugs
With $250M in Financing, AstraZeneca Spinout to Focus on Severe Autoimmune...
Autoimmune Disease Drugs
Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration
Autoimmune Disease Drugs
Biogen CEO Scangos Stepping Down
1
2
3
Page 1 of 3
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![This confocal microscopic image of a healthy mouse T cell uses color florescence to illustrate how the protein Gimap5 (upper-right faint green area) and the enzyme GSK3 (red) overlap in small structures called vesicles inside cells (colocalized yellow area). This happens before GSK3 enters the cell nucleus (shown in blue). This step is important to limit DNA damage in active T cells during their expansion. The image is part of a study published Jan. 30 by Nature Communications from researchers at Cincinnati Children's. [Cincinnati Children's]](https://www.genengnews.com/wp-content/uploads/2018/08/Jan30_2018_CincinnatiChildrens_TCellRegulator1019210011-324x160.jpg "Immune Disorder Trigger Identified")
![GlaxoSmithKline (GSK) has made a $300 million equity investment in 23andMe under a collaboration designed to accelerate development of new therapies for both companies by using genetic data to identify new drug targets. [Source: © fotoliaxrender/Fotolia]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug5_2014_56448122_DNAblue_NovelDiagnosticGenomic12114111424-265x198.jpg "GSK Invests $300M in 23andMe as Companies Collaborate on Drug Development")
